GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » Current Accrued Expense

Acepodia (ROCO:6976) Current Accrued Expense : NT$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Acepodia Current Accrued Expense?

Acepodia's Current Accrued Expense for the quarter that ended in Dec. 2024 was NT$0.00 Mil.


Acepodia Current Accrued Expense Historical Data

The historical data trend for Acepodia's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia Current Accrued Expense Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Current Accrued Expense
- - - - -

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Current Accrued Expense Get a 7-Day Free Trial - - - - -

Acepodia Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Acepodia Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Acepodia's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Acepodia Business Description

Traded in Other Exchanges
N/A
Address
17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia Headlines

No Headlines